Jim Simons started to build up the position in Scopus Biopharma in Q4 2021 and continued to invest until Q2 2022. Since then they sold 131k shares. The investor completely sold their stake between Q3 2022 and Q4 2022.
Avg closing price
Price range
Sold -61.1k shares
Q4 2022
Avg closing price
$0.25
Price range
$0.17
-
$0.37
Sold 53.3% shares (-69.7k shares)
Q3 2022
Avg closing price
$0.36
Price range
$0.23
-
$0.45
Increased shares by 16.3% (+18.3k shares)
Q2 2022
Avg closing price
$0.48
Price range
$0.36
-
$0.73
Increased shares by 438.4% (+91.6k shares)
Q1 2022